Few crises in contemporary medicine carry the scope or urgency of antimicrobial resistance. Decades of unrestricted antibiotic deployment — in hospitals, community clinics, livestock operations, and aquaculture — have imposed a relentless evolutionary pressure on bacterial populations, yielding strains whose survival repertoire now routinely outpaces the drugs designed to eliminate them. Mortality attributable to resistant infections already surpasses one million deaths annually worldwide, a burden that epidemiological modelling suggests could multiply several-fold within a generation if present trajectories continue unchecked.

This review was written to provide a thorough, critically reasoned synthesis of where the field stands. We begin by mapping the epidemiological footprint of resistance across world regions and healthcare contexts, then proceed to a detailed molecular examination of the biological mechanisms through which bacteria thwart antimicrobial agents — from the catalytic destruction of drug molecules to the architectural remodelling of target proteins, from the molecular pumps that purge drugs before they can act to the dormant cell populations that simply wait out antibiotic storms. Particular attention is given to the genomic infrastructure — plasmids, integrons, and transposable elements — that allows resistance traits to cross species lines with startling speed.

Against this mechanistic backdrop, we survey the most promising therapeutic directions that researchers and clinicians are now pursuing: reformulated and structurally novel antibiotics, combination regimens built around adjuvant compounds that neutralise resistance machinery, nanoparticle delivery platforms that ferry drugs past biofilm barriers, bacteriophage-based treatments that exploit viruses as precision bacterial predators, membrane-disrupting antimicrobial peptides, CRISPR nuclease systems repurposed as sequence-directed antibacterials, and the rapidly maturing contribution of machine-learning algorithms to drug identification and resistance forecasting. We conclude by addressing the systemic obstacles — economic, regulatory, and political — that continue to slow progress, and we outline the coordinated, cross-disciplinary response that the magnitude of this challenge demands.

antimicrobial resistance; beta-lactamase; efflux pumps; horizontal gene transfer; biofilm; persister cells; phage therapy; nanoparticle drug delivery; CRISPR antimicrobials; antimicrobial peptides; stewardship; machine learning; multidrug resistance; ESKAPE pathogens; carbapenem resistance; plasmid-mediated resistance; host-directed therapy; resistome; One Health; surveillance genomics

Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-655. doi:10.1016/S0140-6736(21)02724-0

O'Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Review on Antimicrobial Resistance. London: Wellcome Trust; 2016.

World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: WHO Press; 2015. ISBN 9789241509763.

World Health Organization. WHO Priority Pathogens List for Research and Development of New Antibiotics. Geneva: WHO; 2017.

Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA: US CDC; 2019.

Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-281.

Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42-51.

Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem. 2009;78:119-146.

Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):742-750.

Stokes JM, Yang K, Swanson K, et al. A deep learning approach to antibiotic discovery. Cell. 2020;180(4):688-702.e13.

Gordillo Altamirano FL, Barr JJ. Phage therapy in the postantibiotic era. Clin Microbiol Rev. 2019;32(2):e00066-18.

Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 2002;415(6870):389-395.

Bikard D, Euler CW, Jiang W, et al. Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol. 2014;32(11):1146-1150.

Lewis K. Persister cells. Annu Rev Microbiol. 2010;64:357-372.

Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623-633.

Pelgrift RY, Friedman AJ. Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev. 2013;65(13-14):1803-1815.

Piddock LJ. The crisis of no new antibiotics: what is the way forward? Lancet Infect Dis. 2012;12(3):249-253.

Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980;289(1036):321-331.

Ventola CL. The antibiotic resistance crisis: causes and threats. P T. 2015;40(4):277-283.

Coates AR, Halls G, Hu Y. Novel classes of antibiotics or more of the same? Br J Pharmacol. 2011;163(1):184-194.

Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318-327.

Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance — the need for global solutions. Lancet. 2013;382(9912):1057-1098.

Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161-168.

Cassini A, Hogberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015. Lancet Infect Dis. 2019;19(1):56-66.

van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA. 2015;112(18):5649-5654.